{"investor":{"slug":"invus","name":"Invus","website":null,"x_handle":null,"logo":null,"type":"fund","companies":3,"deals":3,"deals_12m":0,"leads":0,"round_capital":507000000,"latest_deal":{"date":"2024-10-21","stage":"series-b+","amount_usd":225000000,"company":{"slug":"seaport-therapeutics-2","name":"Seaport Therapeutics"}}},"profile":null,"fund_returns":[],"portfolio":[{"slug":"seaport-therapeutics-2","name":"Seaport Therapeutics","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9wYnMudHdpbWcuY29tL3Byb2ZpbGVfaW1hZ2VzLzE3NzM0MTI4NjY2ODQ2MDAzMjAvZUdFMnF2X3FfNDAweDQwMC5wbmc","crypto":false,"categories":["health-bio"],"total_raised":325000000,"latest_raise":{"date":"2024-10-21","stage":"series-b+","amount_usd":225000000,"source_url":"https://seaporttx.com/press-release/seaport-therapeutics-closes-225-million-oversubscribed-series-b-financing-round/"},"rounds_with_investor":[{"date":"2024-10-21","stage":"series-b+","amount_usd":225000000,"source_url":"https://seaporttx.com/press-release/seaport-therapeutics-closes-225-million-oversubscribed-series-b-financing-round/","lead":false}]},{"slug":"lifemine-therapeutics","name":"LifeMine Therapeutics","logo":"https://recentfunding.com/logo/d/lifeminetx.com.png","crypto":false,"categories":["health-bio"],"total_raised":543000000,"latest_raise":{"date":"2026-08-06","stage":"series-b+","amount_usd":75000000,"source_url":"https://www.biospace.com/business/lifemine-raises-263m-in-mission-to-improve-organ-transplant-aftercare"},"rounds_with_investor":[{"date":"2022-03-23","stage":"series-b+","amount_usd":175000000,"source_url":"https://fundraisingfox.com/companies/lifemine-therapeutics","lead":false}]},{"slug":"parabilis-medicines","name":"Parabilis Medicines","logo":"https://recentfunding.com/logo/d/parabilismed.com.png","crypto":false,"categories":["health-bio"],"total_raised":801000000,"latest_raise":{"date":"2026-01-08","stage":"series-b+","amount_usd":305000000,"source_url":"https://fundraisingfox.com/companies/parabilis-medicines"},"rounds_with_investor":[{"date":"2021-03-01","stage":"series-b+","amount_usd":107000000,"source_url":"https://www.fiercebiotech.com/biotech/fogpharma-comes-through-clearing-a-meaty-107m-raise-for-undruggable-targets","lead":false}]}],"top_categories":[{"key":"health-bio","label":"Health and bio","companies":3,"share":1}],"allocation":{"stages":[{"key":"series-b+","label":"Series b+","deals":3,"capital":507000000,"share":1}],"years":[{"year":"2021","deals":1,"capital":107000000,"share":0.3333333333333333},{"year":"2022","deals":1,"capital":175000000,"share":0.3333333333333333},{"year":"2024","deals":1,"capital":225000000,"share":0.3333333333333333}]},"co_investors":[{"slug":"arch-venture-partners","name":"ARCH Venture Partners","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2024-10-21"},{"slug":"gv","name":"GV","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9mcmFtZXJ1c2VyY29udGVudC5jb20vaW1hZ2VzL0swN0lTR005bnduMkI0NzlwRmxJckNlNEdrLndlYnA","type":"fund","shared_rounds":2,"last_shared":"2022-03-23"},{"slug":"blue-pool-capital","name":"Blue Pool Capital","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2022-03-23"},{"slug":"t-rowe-price","name":"T. Rowe Price","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"general-atlantic","name":"General Atlantic","logo":"https://recentfunding.com/logo/d/generalatlantic.com.png","type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"cpp-investments","name":"CPP Investments","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"goldman-sachs-alternatives","name":"Goldman Sachs Alternatives","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"foresite-capital","name":"Foresite Capital","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"sofinnova-investments","name":"Sofinnova Investments","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"third-rock-ventures","name":"Third Rock Ventures","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"puretech-health","name":"PureTech Health","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"fidelity-management-research-company","name":"Fidelity Management & Research Company","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2022-03-23"}]}